Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib


Eskazan A. E.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.23, no.2, pp.400-401, 2018 (SCI-Expanded) identifier identifier identifier